Acne, the common skin condition that occurs when hair follicles become plugged with oil and dead skin cells, is most often associated with the awkwardness of adolescence. However, it’s more common in adults, especially adult women, than most realize.
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. In health policy, 2018 and 2019 could look a lot alike.
Takeda Pharmaceutical has completed its acquisition of Shire, 8 months after the deal was announced, according to a press release. The deal was approved by 89.1% of Takeda’s shareholders and 99.8% of Shire’s shareholders, the release said.
Each NACDS member company has a powerful opportunity to submit official comments to the Centers for Medicare & Medicaid Services (CMS) in support of direct and indirect remuneration (DIR) fee reform concepts described in the agency’s proposed rule, “Modernizing Part D and Medicare Advantage to Lower
Propeller Health, a leading digital therapeutics company, today announced announced a partnership with Walgreens on My Pharmacy which connects Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services in the Propeller mobile app.
Shoppers Drug Mart launched its online platform for the sale of medical cannabis, providing patients with a single, trusted source for all their cannabis therapy needs.
Safe Rx announced its product availability in AmerisourceBergen, with merchandising kits available to all AmerisourceBergen California customers.
Cardinal Health announced today it has acquired Mirixa Corp., a leading provider of technology-enabled solutions for the provision of medication therapy management (MTM) services, from the National Community Pharmacists Association (NCPA).
The Campaign for Personal Prescription Importation (CPPI) today released survey results highlighting the reasons Americans continue to purchase their personal prescriptions from licensed and legitimate online pharmacies in Canada, safely, at considerable cost savings, and often at the recommendation
Eli Lilly and Co. and Loxo Oncology, Inc. today announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion.
As part of its long-standing commitment to reduce opioid misuse and abuse, the Cardinal Health Foundation is pleased to announce a $530,000 grant to the Ohio Hospital Association (OHA) to identify and deploy best opioid prescribing practices for pain management among OHA member hospitals across the
Diplomat Pharmacy and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting or expanding their own specialty pharmacy services to benefit from Diplomat’s limited-distribution drug portfolio and e
Drug prices are a major target of patient groups and Congress, although drug spending makes up only 10% of the $3.3 trillion spent on U.S. health care in a year.
Diplomat Pharmacy is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat now expects 2018 revenue to be at the lower end of the previously communicated $5.5 to $5.
WOONSOCKET, RI – A new MinuteClinic walk-in medical clinic has opened inside the CVS Pharmacy store at 5 Church Street in Dallas, Pa., providing the community with convenient access to common health care services. The clinic will be open Monday through Friday with no appointment necessary.
To assist in combatting the national opioid epidemic Hy-Vee announces the implementation of a new controlled substance prescription policy. As of Jan.
